In summary, our study found that high expression of disulfidptosis-related SLC7A11 was associated with migration, invasion, drug sensitivity, immune infiltration disorders, and poor prognosis in ACC, and targeting its metabolic vulnerability to induce disulfidptosis has the potential to improve overall patient survival. Here, SLC7A11 is linked to adrenal cortex carcinoma.